The lipopeptides fengycin and iturin are involved in the anticandidal activity of endophytic Bacillus sp. as determined by experimental and in silico analysis

© 2022 The Society for Applied Microbiology..

In this study, an endophytic Bacillus sp. strain (K7) was isolated from the medicinally important ornamental plant, Jasminum officinale. Biochemical analyses were conducted to evaluate the nature of the extracted product, which displayed strong anticandidal activity against Candida albicans (CA) SC5314, as evident from the results obtained in agar-cup diffusion tests, phase-contrast microscopy, scanning electron microscopy and minimum inhibitory concentration assays. After confirming the presence of the gene clusters encoding the lipopeptides iturins and fengycin in the genome of K7, their corresponding molecular ions were identified using MALDI-TOF-MS. 3D structures of the lipopeptides were downloaded from specific databases and molecular docking was performed against a vital CA enzyme, exo-1,3-beta-glucanase, involved in cell wall remodelling, adhesion to polymer materials and biofilm formation. The docking score of iturins was found to be -8·6 and -8·2 kcal mol-1 and for fengycin it was -9·4 kcal mol-1 , indicating a strong affinity of these cyclic lipopeptides towards exo-1,3-beta-glucanase. The combined in vitro and in silico anticandidal studies suggested that these secreted lipopeptides from Bacillus sp. may be used as potential therapeutics against opportunistic and complicated infections of CA.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:75

Enthalten in:

Letters in applied microbiology - 75(2022), 2 vom: 05. Aug., Seite 450-459

Sprache:

Englisch

Beteiligte Personen:

Banerjee, S [VerfasserIn]
Sen, S [VerfasserIn]
Bhakat, A [VerfasserIn]
Bhowmick, A [VerfasserIn]
Sarkar, K [VerfasserIn]

Links:

Volltext

Themen:

102577-03-7
Anticandidal
Docking
EC 3.2.1.58
Fengycin
Glucan 1,3-beta-Glucosidase
Iturins
Journal Article
Lipopeptides
Peptides, Cyclic

Anmerkungen:

Date Completed 19.08.2022

Date Revised 19.08.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/lam.13750

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM341431850